Literature DB >> 9723640

Relative risk reduction versus number needed to treat as measures of lipid-lowering trial results.

P M Moriarty.   

Abstract

Recent clinical trials dealing with cholesterol reduction in primary and secondary prevention for cardiovascular disease use Relative Risk Reduction to assess their clinical outcomes. Number Needed to Treat is a more valid measurement.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9723640     DOI： 10.1016/s0002-9149(98)00367-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  2 in total

Review 1.  The cost of treating dyslipidaemia using National Cholesterol Education Program (NCEP) guidelines.

Authors:  J M McKenney
Journal:  Pharmacoeconomics       Date:  1998       Impact factor: 4.981

2.  Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial.

Authors:  M G Franzosi; M Brunetti; R Marchioli; R M Marfisi; G Tognoni; F Valagussa
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.